Literature DB >> 23397481

Semaphorins: their dual role in regulating immune-mediated diseases.

Zahava Vadasz1, Elias Toubi.   

Abstract

The semaphorin family members were originally considered to play a role in neurodevelopment, angiogenesis, tumor development, and metastasis. Over the past few years, a growing body of data indicates that semaphorins are involved in the regulation of the immune system, identified in this case as the "immune semaphorins." These semaphorins are involved in almost all phases of both normal and pathological immune responses and were demonstrated to participate in allergic diseases as well as in auto-immune pathologies. Some of them, such as semaphorin 3A (sema3A), is important in downregulating autoimmune diseases by suppressing the over-activity of both T and B cell autoimmunity. In addition, sema3A was shown to enhance the ability of T and B cell regulatory properties and by doing so to control autoimmune diseases, such as systemic lupus erythematosus. Other semaphorins, such as semaphorins 4D and 4A are important in stimulating T and B cells, thus keeping these immune responses on-going. However, when overexpressed, they can induce the induction of many immune-mediated diseases. The importance of all this is to develop targeting therapies that could possibly enhance or alternatively suppress these molecules. In this review, we will focus on several immune semaphorins--their role in immune homeostasis and in immune-mediated diseases.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 23397481     DOI: 10.1007/s12016-013-8360-4

Source DB:  PubMed          Journal:  Clin Rev Allergy Immunol        ISSN: 1080-0549            Impact factor:   8.667


  62 in total

1.  CD72-deficient mice reveal nonredundant roles of CD72 in B cell development and activation.

Authors:  C Pan; N Baumgarth; J R Parnes
Journal:  Immunity       Date:  1999-10       Impact factor: 31.745

Review 2.  Neuropilins, semaphorins, and their role in thymocyte development.

Authors:  Daniella Arêas Mendes-da-Cruz; Yves Lepelletier; Anne C Brignier; Salete Smaniotto; Amédée Renand; Pierre Milpied; Mireille Dardenne; Olivier Hermine; Wilson Savino
Journal:  Ann N Y Acad Sci       Date:  2009-02       Impact factor: 5.691

3.  Topically applied semaphorin 3A ointment inhibits scratching behavior and improves skin inflammation in NC/Nga mice with atopic dermatitis.

Authors:  Osamu Negi; Mitsutoshi Tominaga; Suhandy Tengara; Atsuko Kamo; Kenichi Taneda; Yasushi Suga; Hideoki Ogawa; Kenji Takamori
Journal:  J Dermatol Sci       Date:  2012-01-21       Impact factor: 4.563

Review 4.  Semaphorins and their receptors in stem and cancer cells.

Authors:  C Micucci; S Orciari; A Catalano
Journal:  Curr Med Chem       Date:  2010       Impact factor: 4.530

5.  Intranasal administration of semaphorin-3A alleviates sneezing and nasal rubbing in a murine model of allergic rhinitis.

Authors:  Haruna Sawaki; Fumio Nakamura; Michiko Aihara; Yoji Nagashima; Junko Komori-Yamaguchi; Naoya Yamashita; Masatoshi Nakazawa; Yoshio Goshima; Zenro Ikezawa
Journal:  J Pharmacol Sci       Date:  2011-08-18       Impact factor: 3.337

6.  Semaphorin 7A on keratinocytes induces interleukin-8 production by monocytes.

Authors:  Masahiro Kamata; Yayoi Tada; Hideya Uratsuji; Tomohiko Kawashima; Yoshihide Asano; Makoto Sugaya; Takafumi Kadono; Kunihiko Tamaki; Shinichi Sato
Journal:  J Dermatol Sci       Date:  2011-02-26       Impact factor: 4.563

7.  The leukocyte semaphorin CD100 is expressed in most T-cell, but few B-cell, non-Hodgkin's lymphomas.

Authors:  D M Dorfman; A Shahsafaei; L M Nadler; G J Freeman
Journal:  Am J Pathol       Date:  1998-07       Impact factor: 4.307

8.  Semaphorin3A signaling controls Fas (CD95)-mediated apoptosis by promoting Fas translocation into lipid rafts.

Authors:  Simona Moretti; Antonio Procopio; Raffaella Lazzarini; Maria Rita Rippo; Roberto Testa; Maurizio Marra; Luca Tamagnone; Alfonso Catalano
Journal:  Blood       Date:  2007-12-03       Impact factor: 22.113

Review 9.  Structure and function of the immune semaphorin CD100/SEMA4D.

Authors:  Abdellah Elhabazi; Anne Marie-Cardine; Isabelle Chabbert-de Ponnat; Armand Bensussan; Laurence Boumsell
Journal:  Crit Rev Immunol       Date:  2003       Impact factor: 2.214

10.  Expression of neuroimmune semaphorins 4A and 4D and their receptors in the lung is enhanced by allergen and vascular endothelial growth factor.

Authors:  Elizabeth P Smith; Kathleen Shanks; Michael M Lipsky; Louis J DeTolla; Achsah D Keegan; Svetlana P Chapoval
Journal:  BMC Immunol       Date:  2011-05-19       Impact factor: 3.615

View more
  27 in total

Review 1.  Semaphorin3A: A potential therapeutic tool in immune-mediated diseases.

Authors:  Zahava Vadasz; Elias Toubi
Journal:  Eur J Rheumatol       Date:  2017-12-07

2.  Increased urine semaphorin-3A is associated with renal damage in hypertensive patients with chronic kidney disease: a nested case-control study.

Authors:  Francesca Viazzi; Ganesan Ramesh; Calpurnia Jayakumar; Giovanna Leoncini; Debora Garneri; Roberto Pontremoli
Journal:  J Nephrol       Date:  2014-04-23       Impact factor: 3.902

3.  Semaphorin-3A is a repulsive but attractive renal guidance cue to therapy.

Authors:  Friedrich C Luft
Journal:  J Mol Med (Berl)       Date:  2014-12       Impact factor: 4.599

4.  The DNA methylation profile of activated human natural killer cells.

Authors:  John K Wiencke; Rondi Butler; George Hsuang; Melissa Eliot; Stephanie Kim; Manuel A Sepulveda; Derick Siegel; E Andres Houseman; Karl T Kelsey
Journal:  Epigenetics       Date:  2016-03-11       Impact factor: 4.528

Review 5.  Genetic and Molecular Biology of Multiple Sclerosis Among Iranian Patients: An Overview.

Authors:  Meysam Moghbeli
Journal:  Cell Mol Neurobiol       Date:  2019-09-03       Impact factor: 5.046

6.  Semaphorin 3A: an immunoregulator in systemic sclerosis.

Authors:  Doron Rimar; Yuval Nov; Itzhak Rosner; Gleb Slobodin; Michael Rozenbaum; Katy Halasz; Tharwat Haj; Nizar Jiries; Lisa Kaly; Nina Boulman; Zahava Vadasz
Journal:  Rheumatol Int       Date:  2015-04-21       Impact factor: 2.631

Review 7.  The role of the semaphorins in cancer.

Authors:  Gera Neufeld; Yelena Mumblat; Tatyana Smolkin; Shira Toledano; Inbal Nir-Zvi; Keren Ziv; Ofra Kessler
Journal:  Cell Adh Migr       Date:  2016-08-17       Impact factor: 3.405

Review 8.  Autoimmunity in 2013.

Authors:  Carlo Selmi
Journal:  Clin Rev Allergy Immunol       Date:  2014-08       Impact factor: 8.667

9.  Unique topics and issues in rheumatology and clinical immunology.

Authors:  Carlo Selmi
Journal:  Clin Rev Allergy Immunol       Date:  2014-08       Impact factor: 8.667

10.  Semaphorin4A and H-ferritin utilize Tim-1 on human oligodendrocytes: A novel neuro-immune axis.

Authors:  Brian Chiou; Elisabeth Lucassen; Michael Sather; Asha Kallianpur; James Connor
Journal:  Glia       Date:  2018-02-19       Impact factor: 7.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.